It was reported that on the (b)(6) 2022, a percutaneous coronary intervention (pci) was performed in the mid left anterior descending artery (lad) and two non-abbott stents were implanted.On (b)(6) 2022, after confirming the lesion with the intravascular ultrasound (ivus) a percutaneous coronary intervention (pci) was performed to treat the proximal right coronary artery (rca).A 6fr guide catheter was introduced and the lesion was pre-dilated with an unspecified balloon.The xience skypoint stent was implanted and the procedure was completed.On (b)(6) 2022, the patient developed a stroke and was hospitalized.The patient subsequently recovered after the stroke.On (b)(6) 2023, the patient experienced an st elevated myocardial infarction (stemi).An unknown stent was implanted successfully in the left anterior descending (lad) artery but the patient developed thrombosis, residual emboli in the periphery and a cardiogenic shock with as (aortic stenosis).The patient was hospitalized but died on (b)(6) 2023.The physician stated the xience skypoint stent did not cause or contribute to the patient death.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.The reported patient effect of stroke are listed in the xience skypoint everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|